Anne Nobles, former Senior Vice President, Enterprise Risk Management & Chief Ethics and Compliance Officer, Eli Lilly
NOVEMBER 13, 2014
Anne Nobles retired from Eli Lilly and Company in December 2012 as the Senior VP, Enterprise Risk Management and Chief Ethics and Compliance Officer. Under Anne’s leadership, the company entered into and complied with a corporate integrity agreement with the Office of Inspector General of Health and Human Services, strengthened the global privacy program and substantially enhanced its anti-corruption program. She chaired the company’s compliance committee and served on the company’s executive committee, while working closely with Lilly’s board of directors on compliance and enterprise risk management issues. During her more than 22 years with Lilly, Anne served in a series of roles of increasing importance, including Vice President for Corporate Affairs and leader of the team that developed and launched the first non-stimulant for attention deficit/hyperactivity disorder.
Currently, Anne is chairman of the board of directors of IU Health, the largest health system in Indiana and one of the top-rated systems in the country, according to US News & World Report. She is vice chair of the board of directors of Citizens Energy, an Indianapolis-based utility. In addition, Anne devotes time to not-for-profit organizations in her community, including The Nature Conservancy of Indiana, which she serves as a trustee. She is a member of the Committee of 200, an invitation-only membership organization of the world’s most successful women business leaders.
Anne received her B.A. and M.A. degrees from Harvard University and her J.D. from Georgetown Law School.
She and her husband David Johnson have one daughter, Catherine Nobles Johnson.